Hiroshi Miyake
Fundador en CHORDIA THERAPEUTICS INC. .
Fortuna: 9 $ al 30/04/2024
Perfil
Hiroshi Miyake is the founder and current Chief Executive Officer & Representative Director of Chordia Therapeutics, Inc. which is founded in 2017.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/05/2024 | 900 000 ( 1.37% ) | 9 $ | 30/04/2024 |
Cargos activos de Hiroshi Miyake
| Empresas | Cargo | Inicio |
|---|---|---|
| CHORDIA THERAPEUTICS INC. | Fundador | 12/10/2017 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Chordia Therapeutics, Inc.
 Chordia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chordia Therapeutics, Inc. engages in the research and development of novel therapies for cancers. It handles research and development of low-molecular-weight drugs with unprecedented new mechanisms of action in the oncology area. The company was founded by Hiroshi Miyake and Daisuke Morishita on October 12, 2017 and is headquartered in Fujisawa, Japan. | Health Technology |
- Bolsa de valores
- Insiders
- Hiroshi Miyake
